Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
33%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_3
2
20%
Ph not_applicable
1
10%
Ph phase_4
5
50%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
5(55.6%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(6)
Terminated(2)
Other(2)

Detailed Status

Completed6
unknown2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 32 (22.2%)
Phase 45 (55.6%)
N/A1 (11.1%)

Trials by Status

completed660%
terminated110%
withdrawn110%
unknown220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10